{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:28:11Z","timestamp":1740115691012,"version":"3.37.3"},"posted":{"date-parts":[[2024,4,3]]},"group-title":"In Review","reference-count":52,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,3,29]]},"abstract":"<title>Abstract<\/title>\n        <p>Background\n Hepatitis C virus (HCV) coinfection may further compromise immunological and cognitive function in people with HIV (PWH). This study compared laboratory and neuropsychiatric measures across the periods of HCV seroconversion and direct-acting antiviral (DAA) therapy with sustained virologic response (SVR) among PWH who initiated antiretroviral therapy (ART) during acute HIV infection (AHI) and acquired HCV after 24 weeks of ART.\nMethods\n Participants from the RV254 AHI cohort underwent paired laboratory and neuropsychiatric assessments during regular follow-up. The former included measurements of CD4\u2009+\u2009and CD8\u2009+\u2009T-cell counts, HIV RNA, liver enzymes, and lipid profiles. The latter included the Patient Health Questionnaire-9 (PHQ-9), Distress Thermometer (DT), and a 4-test cognitive battery that evaluated psychomotor speed, executive function, fine motor speed and dexterity. The raw scores in the battery were standardized and averaged to create an overall performance (NPZ-4) score. Parameters of HCV-coinfected participants were compared across HCV seroconversion and DAA treatment groups.\nResults\n Between 2009 and 2022, 79 of 703 RV254 participants acquired HCV after \u2265\u200924 weeks of ART; 53 received DAA, and 50 (94%) achieved SVR. All participants were Thai males (median age: 30 years); 34 (68%) denied past intravenous drug use, and 41 (82%) had a history of other sexually transmitted infections during follow-up. Following SVR, aspartate transferase (AST) and alanine transaminase (ALT) decreased (p\u2009&lt;\u20090.001), while total cholesterol, low-density lipoprotein, and triglycerides increased (p\u2009&lt;\u20090.01). The median CD4+\/CD8\u2009+\u2009ratio increased from 0.91 to 0.97 (p\u2009=\u20090.012). NPZ-4 improved from 0.75 to 0.91 (p\u2009=\u20090.004). The median DT score increased from 1.7 to 2.7 (p\u2009=\u20090.045), but the PHQ-9 score remained unchanged.\nConclusion\n HCV coinfection is common in this group of high-risk PWH, highlighting the need for regular screening, early diagnosis, and treatment. There was a modest improvement in the CD4+\/CD8\u2009+\u2009T-cell ratio and cognitive performance after DAA therapy in patients who achieved SVR. Future studies should examine potential neuropsychiatric impacts during early HCV infection as well as the longer-term neuropsychiatric outcomes after DAA treatment with SVR.<\/p>","DOI":"10.21203\/rs.3.rs-4186965\/v1","type":"posted-content","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T17:01:49Z","timestamp":1712163709000},"source":"Crossref","is-referenced-by-count":0,"title":["Neuropsychiatric and Laboratory Outcomes of Hepatitis C Treatment in an Early-Treated HIV Cohort in Thailand"],"prefix":"10.21203","author":[{"given":"Ferron F.","family":"Ocampo","sequence":"first","affiliation":[{"name":"SEARCH Research Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Sacdalan","sequence":"additional","affiliation":[{"name":"SEARCH Research Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suteeraporn","family":"Pinyakorn","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misti","family":"Paudel","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanyaporn","family":"Wansom","sequence":"additional","affiliation":[{"name":"Dreamlopments Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathornsorn","family":"Poltubtim","sequence":"additional","affiliation":[{"name":"SEARCH Research Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somchai","family":"Sriplienc","sequence":"additional","affiliation":[{"name":"SEARCH Research Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nittaya","family":"Phanuphak","sequence":"additional","affiliation":[{"name":"Institute of HIV Research and Innovation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Paul","sequence":"additional","affiliation":[{"name":"University of Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Hsu","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donn","family":"Colby","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydie","family":"Trautmann","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Spudich","sequence":"additional","affiliation":[{"name":"Yale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Chan","sequence":"additional","affiliation":[{"name":"Yale University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis","volume":"16","author":"Platt L","year":"2016","unstructured":"Platt L, Easterbrook P, Gower E, McDonald B, Sabin K, McGowan C, et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):797\u2013808.","journal-title":"Lancet Infect Dis"},{"issue":"9772","key":"ref2","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(10)62001-6","article-title":"Increasing burden of liver disease in patients with HIV infection","volume":"377","author":"Joshi D","year":"2011","unstructured":"Joshi D, O\u2019Grady J, Dieterich D, Gazzard B, Agarwal K. Increasing burden of liver disease in patients with HIV infection. Lancet. 2011;377(9772):1198\u2013209.","journal-title":"Lancet"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1586\/17474124.2014.876357","article-title":"Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management","volume":"8","author":"5.Kang W","year":"2014","unstructured":"5.Kang W, Tong HI, Sun Y, Lu Y. Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management. Expert Rev Gastroenterol Hepatol. 2014;8(3):247\u201366.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jvh.12447","article-title":"Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients","volume":"23","author":"Fern\u00e1ndez-Montero JV","year":"2015","unstructured":"Fern\u00e1ndez-Montero JV, Barreiro P, de Mendoza C, Labarga P, Soriano V. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients. J Viral Hepatitis. 2015;23(1):47\u201352.","journal-title":"J Viral Hepatitis"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2015.04.021","article-title":"Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006\u20132010","volume":"63","author":"Allison RD","year":"2015","unstructured":"Allison RD, Tong X, Moorman AC, Ly KN, Rupp L, Xu F, et al. Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006\u20132010. J Hepatol. 2015;63(4):822\u20138.","journal-title":"J Hepatol"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jare.2016.09.005","article-title":"Hepatitis C virus infection, and neurological and psychiatric disorders \u2013 A review","volume":"8","author":"Yarlott L","year":"2017","unstructured":"Yarlott L, Heald E, Forton D. Hepatitis C virus infection, and neurological and psychiatric disorders \u2013 A review. J Adv Res. 2017;8(2):139\u201348.","journal-title":"J Adv Res"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/2050640619835394","article-title":"High efficacy of interferon-free therapy for acute hepatitis C in HIV\u2010positive patients","volume":"7","author":"Chromy D","year":"2019","unstructured":"Chromy D, Mandorfer M, Bucsics T, Schwabl P, Scheiner B, Schmidbauer C, et al. High efficacy of interferon-free therapy for acute hepatitis C in HIV\u2010positive patients. United Eur Gastroenterol J. 2019;7(4):507\u201316.","journal-title":"United Eur Gastroenterol J"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3390\/diagnostics11122336","article-title":"Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV\/HCV Coinfected Patients: Monocentric Italian Experience","volume":"11","author":"Marino A","year":"2021","unstructured":"Marino A, Zafarana G, Ceccarelli M, Cosentino F, Moscatt V, Bruno G, et al. Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV\/HCV Coinfected Patients: Monocentric Italian Experience. Diagnostics. 2021;11(12):2336.","journal-title":"Diagnostics"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/gutjnl-2017-313983","article-title":"The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection","volume":"67","author":"Mahale P","year":"2018","unstructured":"Mahale P, Engels EA, Li R, Torres HA, Hwang LY, Brown EL, et al. The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection. Gut. 2018;67(3):553\u201361.","journal-title":"Gut"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/jvh.13584","article-title":"Neuropsychological effects of direct\u2010acting antiviral treatment for Hepatitis C virus subjects: A systematic review","volume":"28","author":"Santos-Lima C","year":"2021","unstructured":"Santos-Lima C, Souza\u2010Marques B, Vieira F, Isabel Schinoni M, Quarantini LC, Abreu N. Neuropsychological effects of direct\u2010acting antiviral treatment for Hepatitis C virus subjects: A systematic review. J Viral Hepat. 2021;28(12):1672\u201382.","journal-title":"J Viral Hepat"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S2055-6640(20)30688-9","article-title":"Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection","volume":"2","author":"Ananworanich J","year":"2016","unstructured":"Ananworanich J, Sacdalan CP, Pinyakorn S, Chomont N, de Souza M, Luekasemsuk T, et al. Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection. J Virus Erad. 2016;2(1):43\u20138.","journal-title":"J Virus Erad"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/2224-3151.206162","article-title":"Services for depression and suicide in Thailand","volume":"6","author":"Supanya S","year":"2017","unstructured":"Supanya S, Kongsuk T, Kenbubpha K, Phimtra S, Sukhawaha S, Leejongpermpoon J. Services for depression and suicide in Thailand. WHO South-East Asia J Public Health. 2017;6(1):34.","journal-title":"WHO South-East Asia J Public Health"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-8-46","article-title":"Reliability and validity of the Thai version of the PHQ-9","volume":"8","author":"Lotrakul M","year":"2008","unstructured":"Lotrakul M, Sumrithe S, Saipanish R. Reliability and validity of the Thai version of the PHQ-9. BMC Psychiatry. 2008;8(1).","journal-title":"BMC Psychiatry"},{"issue":"3","key":"ref14","first-page":"257","article-title":"Validity of the Thai Version of the Distress Thermometer","volume":"58","author":"Jetiyanuwat S","year":"2013","unstructured":"Jetiyanuwat S. Validity of the Thai Version of the Distress Thermometer. J Psychiatric Association Thail. 2013;58(3):257\u201370.","journal-title":"J Psychiatric Association Thail"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9","volume":"16","author":"Kroenke K","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X","article-title":"Rapid screening for psychologic distress in men with prostate carcinoma","volume":"82","author":"Roth AJ","year":"1998","unstructured":"Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma. Cancer. 1998;82(10):1904\u20138.","journal-title":"Cancer"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13803395.2012.733682","article-title":"Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders","volume":"35","author":"Heaps J","year":"2013","unstructured":"Heaps J, Valcour V, Chalermchai T, Paul R, Rattanamanee S, Siangphoe U, et al. Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders. J Clin Exp Neuropsychol. 2013;35(1):1\u20138.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/QAI.0000000000002356","article-title":"Brief Report: Group Sex and Methamphetamine Use Fuel an Explosive Epidemic of Hepatitis C Among HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand","volume":"84","author":"Wansom T","year":"2020","unstructured":"Wansom T, Pinyakorn S, Kolsteeg CJ, Kroon E, Sacdalan CP, Chomchey N, et al. Brief Report: Group Sex and Methamphetamine Use Fuel an Explosive Epidemic of Hepatitis C Among HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand. J Acquir Immune Defic Syndr. 2020;84(4):331\u20135.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/liv.14578","article-title":"Large transmission cluster of acute hepatitis C identified among HIV-positive men who have sex with men in Bangkok, Thailand","volume":"40","author":"Han WM","year":"2020","unstructured":"Han WM, Colby DJ, Khlaiphuengsin A, Apornpong T, Kerr SJ, Ubolyam S, et al. Large transmission cluster of acute hepatitis C identified among HIV-positive men who have sex with men in Bangkok, Thailand. Liver Int. 2020;40(9):2104\u20139.","journal-title":"Liver Int"},{"issue":"19","key":"ref20","doi-asserted-by":"crossref","first-page":"e20156","DOI":"10.1097\/MD.0000000000020156","article-title":"Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents","volume":"99","author":"Chen YC","year":"2020","unstructured":"Chen YC, Tseng CW, Tseng KC. Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents. Medicine. 2020;99(19):e20156.","journal-title":"Medicine"},{"issue":"22","key":"ref21","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1182\/blood.V128.22.5967.5967","article-title":"Platelet Count Increase Seen with Ledipasvir-Sofosbuvir Combination Treatment of Chronic Hepatitis C in Patients with Thrombocytopenia","volume":"128","author":"Rafei H","year":"2016","unstructured":"Rafei H, Ascensao JL, Aggarwal A. Platelet Count Increase Seen with Ledipasvir-Sofosbuvir Combination Treatment of Chronic Hepatitis C in Patients with Thrombocytopenia. Blood. 2016;128(22):5967\u20135967.","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/8811203","article-title":"Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease","volume":"2021","author":"Saif-Al-Islam M","year":"2021","unstructured":"Saif-Al-Islam M, Abdelaal UM, Younis MA, Alghany Algahlan HA, Khalaf S. Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease. Gastroenterol Res Pract. 2021;2021:1\u201310.","journal-title":"Gastroenterol Res Pract"},{"issue":"26","key":"ref23","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.3748\/wjg.v23.i26.4669","article-title":"Impact of hepatitis C oral therapy in portal hypertension","volume":"23","author":"Lib\u00e2nio D","year":"2017","unstructured":"Lib\u00e2nio D, Marinho RT. Impact of hepatitis C oral therapy in portal hypertension. World J Gastroenterol. 2017;23(26):4669\u201374.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"1435124","DOI":"10.1080\/19932820.2018.1435124","article-title":"Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs","volume":"13","author":"Sagheer G","year":"2018","unstructured":"El Sagheer G, Soliman E, Ahmad A, Hamdy L. Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs. Libyan J Med. 2018;13(1):1435124.","journal-title":"Libyan J Med"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jmv.25062","article-title":"Effect of treatment with direct acting antivirals on body mass index and hepatic steatosis in chronic hepatitis C","volume":"90","author":"Shousha HI","year":"2018","unstructured":"Shousha HI, Abdelaziz RA, Azab SM, Khairy M, Afifi SA, Mehrez MI, et al. Effect of treatment with direct acting antivirals on body mass index and hepatic steatosis in chronic hepatitis C. J Med Virol. 2018;90(6):1099\u2013105.","journal-title":"J Med Virol"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.21608\/mjvh.2021.158275","article-title":"Impact of Direct-Acting Antiviral Agents Treatment on Body Mass Index and Lipid Profile in Egyptian Chronic Hepatitis C Patients","volume":"5","author":"Menesy A","year":"2021","unstructured":"Menesy A, Ehab A, Abbas N. Impact of Direct-Acting Antiviral Agents Treatment on Body Mass Index and Lipid Profile in Egyptian Chronic Hepatitis C Patients. Med J Viral Hepat. 2021;5(2):21\u20136.","journal-title":"Med J Viral Hepat"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/v13071402","article-title":"Impact of HCV Eradication on Lipid Metabolism in HIV\/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study","volume":"13","author":"Spaziante M","year":"2021","unstructured":"Spaziante M, Taliani G, Marchetti G, Tavelli A, Lichtner M, Cingolani A, et al. Impact of HCV Eradication on Lipid Metabolism in HIV\/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study. Viruses. 2021;13(7):1402.","journal-title":"Viruses"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5604\/01.3001.0010.7536","article-title":"Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment","volume":"17","author":"Gitto S","year":"2018","unstructured":"Gitto S, Cicero AFG, Loggi E, Giovannini M, Conti F, Grandini E, et al. Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment. Ann Hepatol. 2018;17(1):64\u201375.","journal-title":"Ann Hepatol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/QAD.0000000000001745","article-title":"Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy","volume":"32","author":"Willis SJ","year":"2018","unstructured":"Willis SJ, Cole SR, Westreich D, Edmonds A, Hurt CB, Albrecht S, et al. Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy. AIDS. 2018;32(5):653\u201361.","journal-title":"AIDS"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/QAD.0000000000000650","article-title":"Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy","volume":"29","author":"Zaegel-Faucher O","year":"2015","unstructured":"Zaegel-Faucher O, Bregigeon S, Cano CE, Obry-Roguet V, Nicolino-Brunet C, Tamalet C, et al. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy. AIDS. 2015;29(12):1505\u201310.","journal-title":"AIDS"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/QAI.0000000000000928","article-title":"Association of Hepatitis C Virus Infection With CD4\/CD8 Ratio in HIV-Positive Women","volume":"72","author":"Kuniholm MH","year":"2016","unstructured":"Kuniholm MH, O\u02bcBrien TR, Prokunina-Olsson L, Augenbraun M, Plankey M, Karim R, et al. Association of Hepatitis C Virus Infection With CD4\/CD8 Ratio in HIV-Positive Women. J Acquir Immune Defic Syndr. 2016;72(2):162\u201370.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jvh.13488","article-title":"The impact of DAA-mediated HCV eradication on CD4\u2009+\u2009and CD8\u2009+\u2009T lymphocyte trajectories in HIV\/HCV coinfected patients: Data from the ICONA Foundation Cohort","volume":"28","author":"Bandera A","year":"2021","unstructured":"Bandera A, Lorenzini P, Taramasso L, Cozzi-Lepri A, Lapadula G, Mussini C, et al. The impact of DAA-mediated HCV eradication on CD4\u2009+\u2009and CD8\u2009+\u2009T lymphocyte trajectories in HIV\/HCV coinfected patients: Data from the ICONA Foundation Cohort. J Viral Hepat. 2021;28(5):779\u201386.","journal-title":"J Viral Hepat"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/infdis\/jiy136","article-title":"Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV\/HCV-Coinfected Patients","volume":"218","author":"L\u00f3pez-Cort\u00e9s LF","year":"2018","unstructured":"L\u00f3pez-Cort\u00e9s LF, Trujillo-Rodr\u00edguez M, B\u00e1ez-Palomo A, Benmarzouk-Hidalgo OJ, Dominguez-Molina B, Milan\u00e9s-Guisado Y, et al. Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV\/HCV-Coinfected Patients. J Infect Dis. 2018;218(4):624\u201332.","journal-title":"J Infect Dis"},{"year":"2022","author":"Laguno M","key":"ref34","unstructured":"Laguno M, Mart\u00ednez-Rebollar M, Casanova M, de Lazzari E, Gonz\u00e1lez-Cord\u00f3n A, Torres B et al. Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients. Clinical Microbiology and Infection. 2022;28(4):610.e1-610.e7."},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.3748\/wjg.v21.i8.2269","article-title":"Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview","volume":"21","author":"Adinolfi LE","year":"2015","unstructured":"Adinolfi LE, Nevola R, Lus G, Restivo L, Guerrera B, Romano C, et al. Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. World J Gastroenterol. 2015;21(8):2269\u201380.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00126334-200402010-00005","article-title":"Psychomotor Slowing in Hepatitis C and HIV Infection","volume":"35","author":"Giesen HJ","year":"2004","unstructured":"von Giesen HJ, Heintges T, Abbasi-Boroudjeni N, K\u00fcc\u00fckk\u00f6yl\u00fc S, K\u00f6ller H, Haslinger BA, et al. Psychomotor Slowing in Hepatitis C and HIV Infection. JAIDS J Acquir Immune Defic Syndr. 2004;35(2):131\u20137.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"Suppl 3","key":"ref37","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/01.aids.0000192072.80572.43","article-title":"The neuropsychological and neurological impact of hepatitis C virus coinfection in HIV-infected subjects","volume":"19","author":"Clifford DB","year":"2005","unstructured":"Clifford DB, Evans SR, Yang Y, Gulick RM. The neuropsychological and neurological impact of hepatitis C virus coinfection in HIV-infected subjects. AIDS. 2005;19(Suppl 3):S64\u201371.","journal-title":"AIDS"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/jnnp.74.9.1267","article-title":"Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia","volume":"74","author":"Nemni R","year":"2003","unstructured":"Nemni R. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry. 2003;74(9):1267\u201371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1111\/liv.15002","article-title":"Peripheral neuropathy after viral eradication with direct-acting antivirals in chronic HCV hepatitis: A prospective study","volume":"41","author":"Zanone MM","year":"2021","unstructured":"Zanone MM, Marinucci C, Ciancio A, Cocito D, Zardo F, Spagone E, et al. Peripheral neuropathy after viral eradication with direct-acting antivirals in chronic HCV hepatitis: A prospective study. Liver Int. 2021;41(11):2611\u201321.","journal-title":"Liver Int"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3390\/diagnostics12051177","article-title":"Perceived Stress in Hepatitis C Virus Infected Patients under the DAA-Based Therapy","volume":"12","author":"Danilescu CM","year":"2022","unstructured":"Danilescu CM, Ionescu M, Sandulescu DL, Pirlog MC, Streba CT, Rogoveanu I. Perceived Stress in Hepatitis C Virus Infected Patients under the DAA-Based Therapy. Diagnostics. 2022;12(5):1177.","journal-title":"Diagnostics"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1188\/17.ONF.329-336","article-title":"The Distress Thermometer: Cutoff Points and Clinical Use","volume":"44","author":"Cutillo A","year":"2017","unstructured":"Cutillo A, O'Hea E, Person S, Lessard D, Harralson T, Boudreaux E. The Distress Thermometer: Cutoff Points and Clinical Use. Oncol Nurs Forum. 2017;44(3):329\u201336.","journal-title":"Oncol Nurs Forum"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/jhep.2002.31257","article-title":"Neuropsychological impairment in patients with chronic hepatitis C","volume":"35","author":"Hilsabeck RC","year":"2002","unstructured":"Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology. 2002;35(2):440\u20136.","journal-title":"Hepatology"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1017\/S1355617703960048","article-title":"Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C","volume":"9","author":"Hilsabeck RC","year":"2003","unstructured":"Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc. 2003;9(6):847\u201357.","journal-title":"J Int Neuropsychol Soc"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11901-007-0017-4","article-title":"Impact of hepatitis C coinfection on cognitive outcomes in HIV-infected individuals","volume":"6","author":"Paul R","year":"2007","unstructured":"Paul R, Letendre S, Dearborn J. Impact of hepatitis C coinfection on cognitive outcomes in HIV-infected individuals. Curr Hepat rep. 2007;6(4):145\u201352.","journal-title":"Curr Hepat rep"},{"issue":"1\u20132","key":"ref45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2011.08.025","article-title":"Hepatitis C virus coinfection increases neurocognitive impairment severity and risk of death in treated HIV\/AIDS","volume":"312","author":"Vivithanaporn P","year":"2012","unstructured":"Vivithanaporn P, Nelles K, DeBlock L, Newman SC, Gill MJ, Power C. Hepatitis C virus coinfection increases neurocognitive impairment severity and risk of death in treated HIV\/AIDS. J Neurol Sci. 2012;312(1\u20132):45\u201351.","journal-title":"J Neurol Sci"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/QAI.0b013e31827b61f1","article-title":"Differential Cognitive Impairment in HCV Coinfected Men With Controlled HIV Compared to HCV Monoinfection","volume":"62","author":"Sun B","year":"2013","unstructured":"Sun B, Abadjian L, Rempel H, Monto A, Pulliam L. Differential Cognitive Impairment in HCV Coinfected Men With Controlled HIV Compared to HCV Monoinfection. JAIDS J Acquir Immune Defic Syndr. 2013;62(2):190\u20136.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"ref47","article-title":"Neurocognitive Trajectories After 72 Weeks of First-Line Anti-retroviral Therapy in Vietnamese Adults With HIV-HCV Coinfection","volume":"12","author":"Paul RH","year":"2021","unstructured":"Paul RH, Shikuma CM, Chau NVV, Ndhlovu LC, Thanh NT, Belden AC et al. Neurocognitive Trajectories After 72 Weeks of First-Line Anti-retroviral Therapy in Vietnamese Adults With HIV-HCV Coinfection. Front Neurol. 2021;12.","journal-title":"Front Neurol"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s13365-018-0647-z","article-title":"Interferon-free therapy in hepatitis C virus (HCV) monoinfected and HCV\/HIV coinfected patients: effect on cognitive function, fatigue, and mental health","volume":"24","author":"Kleefeld F","year":"2018","unstructured":"Kleefeld F, Heller S, Ingiliz P, Jessen H, Petersen A, Kopp U, et al. Interferon-free therapy in hepatitis C virus (HCV) monoinfected and HCV\/HIV coinfected patients: effect on cognitive function, fatigue, and mental health. J Neurovirol. 2018;24(5):557\u201369.","journal-title":"J Neurovirol"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/infdis\/jiaa109","article-title":"Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms","volume":"222","author":"Sun B","year":"2020","unstructured":"Sun B, Abadjian L, Monto A, Freasier H, Pulliam L. Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms. J Infect Dis. 2020;222(3):396\u2013406.","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"ref50","first-page":"S222","article-title":"Practice effect and normative data of an HIV-specific neuropsychological testing battery among healthy Thais","volume":"97","author":"Sithinamsuwan P","year":"2014","unstructured":"Sithinamsuwan P, Hutchings N, Ananworanich J, Wendelken L, Saengtawan P, Paul R, et al. Practice effect and normative data of an HIV-specific neuropsychological testing battery among healthy Thais. J Med Assoc Thai. 2014;97(Suppl 2):S222\u201333.","journal-title":"J Med Assoc Thai"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11065-009-9092-3","article-title":"Neuropsychological functioning and antiretroviral treatment in HIV\/AIDS: a review","volume":"19","author":"Cysique LA","year":"2009","unstructured":"Cysique LA, Brew BJ. Neuropsychological functioning and antiretroviral treatment in HIV\/AIDS: a review. Neuropsychol Rev. 2009;19(2):169\u201385.","journal-title":"Neuropsychol Rev"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/QAD.0000000000001848","article-title":"Long terms trends in CD4\u2009+\u2009cell counts, CD8\u2009+\u2009cell counts, and the CD4+\u200a: \u200aCD8\u2009+\u2009ratio","volume":"32","author":"Hughes RA","year":"2018","unstructured":"Hughes RA, May MT, Tilling K, Taylor N, Wittkop L, Reiss P, et al. Long terms trends in CD4\u2009+\u2009cell counts, CD8\u2009+\u2009cell counts, and the CD4+\u200a: \u200aCD8\u2009+\u2009ratio. AIDS. 2018;32(10):1361\u20137.","journal-title":"AIDS"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4186965\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4186965\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T15:48:55Z","timestamp":1740066535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4186965\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,3]]},"references-count":52,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4186965\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12981-025-00707-x","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,4,3]]},"subtype":"preprint"}}